61![Michael Hill, et al. v. Accentia Biopharmaceuticals, Inc., et al. 13-CV[removed]Order Michael Hill, et al. v. Accentia Biopharmaceuticals, Inc., et al. 13-CV[removed]Order](https://www.pdfsearch.io/img/1a3d0f7e1d179b5c86fb700888f9870d.jpg) | Add to Reading ListSource URL: securities.stanford.eduLanguage: English - Date: 2015-02-05 17:18:37
|
---|
62![Angebot/Offered place(s) 1. Stellentitel/ Offer title: Particle-based formulation of biopharmaceuticals (postgraduate, Ph.D. student) 2. Fraunhofer Forschungsinstitut/ Research Institute Name des Instituts/ Name of Res Angebot/Offered place(s) 1. Stellentitel/ Offer title: Particle-based formulation of biopharmaceuticals (postgraduate, Ph.D. student) 2. Fraunhofer Forschungsinstitut/ Research Institute Name des Instituts/ Name of Res](https://www.pdfsearch.io/img/26bac06797f9bbf72edc8b089c0af492.jpg) | Add to Reading ListSource URL: www.igb.fraunhofer.deLanguage: English - Date: 2015-01-15 07:30:06
|
---|
63![Production and Control of Biosimilars versus Innovators Antonio da Silva, Head Preclinical Development Hexal / Sandoz Biopharmaceuticals Lisbon, 03 April 2013 © 2013 Hexal AG, All rights reserved. All trademarks are the Production and Control of Biosimilars versus Innovators Antonio da Silva, Head Preclinical Development Hexal / Sandoz Biopharmaceuticals Lisbon, 03 April 2013 © 2013 Hexal AG, All rights reserved. All trademarks are the](https://www.pdfsearch.io/img/e11964250c35d6e294a337948598e477.jpg) | Add to Reading ListSource URL: www.egagenerics.comLanguage: English - Date: 2014-12-27 09:48:37
|
---|
64![Investigational Biopharmaceuticals 1
2 Investigational Biopharmaceuticals 1
2](https://www.pdfsearch.io/img/dc105dcdab85f66525ce0a0162af41db.jpg) | Add to Reading ListSource URL: www.igb.fraunhofer.deLanguage: English - Date: 2015-01-15 18:12:12
|
---|
65![Investigational Biopharmaceuticals 1
2 Investigational Biopharmaceuticals 1
2](https://www.pdfsearch.io/img/ca56a836ebb11aab44c709bf00554695.jpg) | Add to Reading ListSource URL: www.item.fraunhofer.deLanguage: English - Date: 2015-01-15 09:49:15
|
---|
66![New Option Listings - September 30, 2014 Exchange/Memo ID:[removed]ONN / OCC ID: Memo Description New Option Listings - September 30, 2014 Exchange/Memo ID:[removed]ONN / OCC ID: Memo Description](https://www.pdfsearch.io/img/7c2bdd4fafe1138e06dbee952de2d292.jpg) | Add to Reading ListSource URL: boxexchange.comLanguage: English - Date: 2014-09-30 14:11:31
|
---|
67![Oct 27-29, 2014 Nigel Rulewski TENTATIVE SCIENTIFIC PROGRAM Eminent Speakers Oct 27-29, 2014 Nigel Rulewski TENTATIVE SCIENTIFIC PROGRAM Eminent Speakers](https://www.pdfsearch.io/img/f2e286f4277a2a1e4ee35560810af286.jpg) | Add to Reading ListSource URL: www.pharmaceuticalconferences.comLanguage: English - Date: 2014-10-15 07:40:23
|
---|
68![Light Scattering for the Masses™ Protein Aggregate Removal with the DynaPro DLS Plate Reader he presence of aggregation in immunoglobulin biopharmaceuticals is a significant concern during all phases of drug developmen Light Scattering for the Masses™ Protein Aggregate Removal with the DynaPro DLS Plate Reader he presence of aggregation in immunoglobulin biopharmaceuticals is a significant concern during all phases of drug developmen](https://www.pdfsearch.io/img/1a77102234d898e309c9532e9b624128.jpg) | Add to Reading ListSource URL: www.wyatt.comLanguage: English - Date: 2012-02-24 16:46:35
|
---|
69![Comprehensive structural characterization of biopharmaceuticals by top-down mass spectrometry and hydrogen/deuterium exchange: implication for biosimilars Jingxi Pan, Derek Smith, Christoph H. Borchers UVic-Genome BC Pro Comprehensive structural characterization of biopharmaceuticals by top-down mass spectrometry and hydrogen/deuterium exchange: implication for biosimilars Jingxi Pan, Derek Smith, Christoph H. Borchers UVic-Genome BC Pro](https://www.pdfsearch.io/img/4b93f465c5c63fdfad91f2aff45fdb29.jpg) | Add to Reading ListSource URL: www.proteincentre.comLanguage: English - Date: 2014-06-23 05:00:11
|
---|
70![Collaborating for Cures Leveraging Global Public-Private Partnerships to Accelerate Biopharmaceuticals Development First Joint IMI & C-Path Forum on the Value of PPPs Thursday 7 March 2013 – Brussels, Belgium The Shera Collaborating for Cures Leveraging Global Public-Private Partnerships to Accelerate Biopharmaceuticals Development First Joint IMI & C-Path Forum on the Value of PPPs Thursday 7 March 2013 – Brussels, Belgium The Shera](https://www.pdfsearch.io/img/538224d9ebdfe4fbc201483039748c88.jpg) | Add to Reading ListSource URL: c-path.orgLanguage: English - Date: 2014-02-20 17:49:57
|
---|